Biography
Diana Coman received her BSc in Biomedical Science from the University of Bedfordshire in 2016, which she followed up with an MSc in Immunology and Allergy at the University of Nottingham. Upon completing her studies, she entered the Cell and Gene Therapy industry as a Research Associate for a cancer immunotherapy company, where she contributed to the enhancement of CAR-T manufacturing processes.
In 2020 she joined the Neves Lab as a PhD student researching the roles of murine Type 3 Innate Lymphoid Cells (ILC3s) derived TGF-β1 in intestinal immune-epithelial interactions. Following the completion of her doctorate., Diana started a new position as a Research Associate in the Neves Lab. In this capacity, she continues her research, focusing on human ILC3s and their roles in maintaining intestinal homeostasis and contributing to inflammation.
Research
Neves Lab
The Neves lab aims understand how the different cellular compartments of the gut communicate with each other, to then be able to direct those conversations to promote gut homeostasis.
News
Gut and lung organoids open the door to innate immune cell therapies
King’s researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.
Research
Neves Lab
The Neves lab aims understand how the different cellular compartments of the gut communicate with each other, to then be able to direct those conversations to promote gut homeostasis.
News
Gut and lung organoids open the door to innate immune cell therapies
King’s researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.